Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Loading…
Jordan's Crossing Herbal Connections sold an unapproved drug called "Germaphobe's Delight Spray" through its website and social media channels, claiming it could mitigate, prevent, treat, diagnose, or cure COVID-19, in violation of section 505(a) of the Federal Food, Drug, and Cosmetic Act. The product was also misbranded under section 502 of the FD&C Act and was introduced into interstate commerce without FDA approval or authorization. The FDA took this enforcement action during the COVID-19 public health emergency declared in January 2020, as part of urgent measures to protect consumers from unapproved products making disease claims.